{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"AbCellera Biologics Inc."},"Symbol":{"label":"Symbol","value":"ABCL"},"Address":{"label":"Address","value":"2215 YUKON STREET, VANCOUVER, British Columbia, V5Y 0A1, Canada"},"Phone":{"label":"Phone","value":"+1 604 559-9005"},"Industry":{"label":"Industry","value":"Pharmaceuticals and Biotechnology"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners."},"CompanyUrl":{"label":"Company Url","value":"https://www.abcellera.com"},"KeyExecutives":{"label":"Key Executives","value":[]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}